A phase II study of pimavanserin as a mono-therapy treatment for the maintenance phase of schizophrenia
Latest Information Update: 08 Oct 2015
At a glance
- Drugs Pimavanserin (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 08 Oct 2015 New trial record